BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 22, 2004
View Archived Issues
BMS Drops Flamel’s Basulin; Shares Suffer 22 Percent Hit
It may be true that “two out of three ain’t bad” - but two pieces of good news and one seriously negative item added up to trouble on Wall Street for Flamel Technologies SA. (BioWorld International)
Read More
Acambis Falls On Cancelled Smallpox Contract From CDC
Read More
Angiogenesis Study Turns Up Male Infertility Surprise Factor
Read More
CeNeS Reports Positive Phase III M6G Data In Post-Operative Pain
Read More
Active Biotech Seeking SEK150M In Convertible Debentures Issue
Read More
Genetic Markers Of Epidermis Cell Differentiation Identified
Read More
Novagali Pharma Completes Second Round For EUR14.2M
Read More
EU Medicines Guidelines Up For General Comment
Read More
Other News To Note
Read More